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Introduction
Reduction of ovarian reserve has been observed in child-
hood-onset SLE (c-SLE) and adult SLE populations, and
most of them were limited to follicle stimulating hormone
(FSH) levels and few recent reports included antral follicle
count (AFC) and/or anti-Müllerian hormone (AMH)
levels. In addition, the contribution of diminished follicle
ovarian pool using anti-corpus luteum antibodies
(anti-CoL) was not available in pediatric lupus population.
Objectives
There are, however, no data regarding the impact of iso-
lated methotrexate exposure and anti-CoL in ovarian
reserve of adult c-SLE patients.
Methods
Fifty-seven adult c-SLE female patients and 21 healthy
controls were evaluated for anti-CoL by immunoblot.
Complete ovarian function was assessed on the early folli-
cular phase of the menstrual cycle or randomly for those
with sustained amenorrhea, blinded to the other para-
meters of ovarian function. Ovarian reserve was assessed
by: FSH, luteinizing hormone (LH), estradiol, AMH and
AFC in patients without hormonal contraception for at
least 12 consecutive months. Demographic data, menstrual
abnormalities, disease activity, damage and treatment were
also studied.
Results
The median of current age was similar in adult c-SLE
patients and controls (27.7. vs. 27.7 years, p = 0.414). The
median of AMH levels (1.1 vs. 1.5 ng/mL, p = 0.037) and
AFC (6 vs. 16, p < 0.001) were significantly reduced in SLE
patients versus controls without any significant menstrual
abnormalities. Anti-CoL was solely observed in SLE
patients (16% vs. 0%, p = 0.103) and not associated with
demographic data, ovarian reserve parameters, disease
activity/damage and treatment. Further evaluation of
patients treated with cyclophosphamide revealed a higher
median of FSH levels compared to SLE patients not trea-
ted with cyclophosphamide and with controls (8.8 vs. 5.7
vs. 5.6 IU/L, p = 0.032) and a lower median AMH levels
(0.4 vs. 1.5 vs. 1.5 ng/mL, p = 0.004) and AFC (4.0 vs. 6.5
vs. 16 IU/L, p = 0.001). Nineteen patients were treated
with methotrexate without cyclophosphamide use, and a
negative correlation was observed between cumulative
methotrexate dose and AMH levels (r = -0.507, p = 0.027).
Conclusion
The present study demonstrated for the first time that
high cumulative methotrexate dose is a possible relevant
cause of subclinical ovarian dysfunction in adult c-SLE
patients and confirms the deleterious effect of cyclopho-
sphamide. These data reinforce the need of gonadal
protection during immunosuppressive treatment and
fertility counseling.
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